By Tim Boyer G+ June 27, 2012 – 2:48pm for eMaxHealth
Diet and Weight Loss Current News
Weight loss plays an important role in the treatment of Type 2 diabetes. Health experts say that just a loss of approximately 5% of a diabetic patient’s weight can result in improved glycemic control. However, Type 2 diabetics typically find it more difficult to lose weight than non-diabetics. In fact, researchers say that diet and exercise are not enough to help diabetics lose weight and that drug intervention is needed that is effective, safe and can be taken in conjunction with blood-sugar medications for treating their diabetes. This week, researchers announce in a free online journal article published in the journal Obesity that the diet pill lorcaserin has demonstrated significant weight loss in patients with Type 2 diabetes.
Lorcaserin is a serotonin receptor angonist that works specifically on appetite signals in the brain and has been shown in previous studies—with otherwise healthy obese individuals—to cause significant weight loss. Encouraged by the previous weight loss findings with lorcaserin, researchers from a variety of academic institutions and members of The Obesity Society (TOS), worked together to determine whether or not lorcaserin is safe and effective in the treatment of overweight patients with Type 2 diabetes.
In a study titled BLOOM-DM (Behavioral Modification and Lorcaserin for Obesity and Overweight Management in Diabetes Mellitus), researchers recruited 604 obese and overweight participants for a year-long, randomized, double-blind, placebo controlled trial. The participants were divided into 3 groups with one group receiving 10 milligrams of lorcasein twice a day in the morning and the evening; the second group received 10 milligrams of lorcasein once a day in the morning and a placebo in the evening; and, the third group receiving a placebo twice a day with one pill in the morning and one in the evening.
click to view more